secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001193125-21-318400
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin CAO Andrea Acosta resigns; CFO Mueller to serve as interim principal accounting officer
--------------------------------------------------------------------------------

- Andrea Acosta, Group VP and CAO, resigns effective Jan 28, 2022 to pursue another career opportunity.
- Company will search for a successor; if none appointed by Jan 28, CFO Brian Mueller will serve as principal accounting officer.
- Mueller will continue as CFO with no adjustment to compensation for additional duties.
- Mueller's bio previously disclosed in 2021 proxy; no related party transactions reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312521318400/0001193125-21-318400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312521318400/d106684d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-318400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer